Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2

To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19 and the current standard care relies on supportive treatments. Therefore, based on the fast and global spread of the virus, urgent investigations are warranted in order to develop preventive and therapeutic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Catanzaro, Michele, Fagiani, Francesca, Racchi, Marco, Corsini, Emanuela, Govoni, Stefano, Lanni, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255975/
https://www.ncbi.nlm.nih.gov/pubmed/32467561
http://dx.doi.org/10.1038/s41392-020-0191-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255975/
https://www.ncbi.nlm.nih.gov/pubmed/32467561
http://dx.doi.org/10.1038/s41392-020-0191-1

Ejemplares similares